Astellas secures acquisition of OSI Pharma, raising its offer to $4 billion – The Pharma Letter
By Dr. Matthew Watson
 RTT News | Astellas secures acquisition of OSI Pharma, raising its offer to $4 billion The Pharma Letter Japanese drug major Astellas Pharma late Sunday night said it has finally reached agreement to acquire the US biotechnology firm OSI Pharmaceuticals, ... Tokyo drugmaker buying OSI of Melville for $4BNewsday (subscription) Astellas Pharma to buy OSI Pharma for $4 billionInternational Business Times US SMALL/MIDCAPS-Stocks rally late as M&A offsets weak energyReuters RTT News -Wall Street Journal (blog) -PR Newswire (press release) all 401 news articles » |
Uncategorized
Comments Off on Astellas secures acquisition of OSI Pharma, raising its offer to $4 billion – The Pharma Letter |
May 18th, 2010
This author published 5472 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research